Spectral AI, Inc. announced on October 14, 2024, that its founder, Dr. J. Michael DiMaio, has been named Chairman of the Board of Directors. This appointment marks Dr. DiMaio's return to a leadership role, having previously served as CEO and Chairman from 2011 to 2020.
In conjunction with this change, Peter Carlson is transitioning out of his role as Chief Executive Officer and from the Board of Directors to pursue other business opportunities. He will continue to serve as a consultant to the company.
The company also established an 'Office of the Chairman' to assume day-to-day operational responsibilities, focusing on clinical development, commercialization of the DeepView System, and engagement with BARDA, the FDA, and strategic relationships. This office will comprise key executives including the CFO, Chief Commercialization Officer, Interim COO, and General Manager.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.